Population pharmacokinetics II: estimation methods

The Annals of Pharmacotherapy
Ene I Ette, Paul J Williams

Abstract

To present, compare, and contrast the various approaches to estimating population pharmacokinetic (PPK) models with respect to the mathematical foundation, statistical aspects, software programs for implementation, and underlying assumptions. Information on PPK was retrieved from a MEDLINE search (1977-August 2004) of literature and a bibliographic review of review articles and books. This information is used in conjunction with experience to explain the various methodologic approaches to PPK. All articles indentified from data sources were evaluated and relevant information was included in this review. Over 80 articles dealing with PPK estimation methods and/or their implementation were identified and reviewed. Sixty-four of these were chosen for their direct relevance to the subject of this article. Different estimation methods ranging from the naive averaging and naive pooled approaches through the standard two-stage approach to the nonlinear mixed-effects modeling approaches for estimating PPK are reviewed with their advantages and limitations. PPK estimation methods that rely on the characterizing of mixed (fixed and random) effects are known to produce PPK parameter estimates that are less biased than those obtained using...Continue Reading

References

Oct 1, 1992·Journal of Pharmacokinetics and Biopharmaceutics·M Davidian, A R Gallant
Jun 1, 1992·Pharmaceutical Research·L L GustafssonS L Shafer
Oct 1, 1992·Statistics in Medicine·E F Vonesh
Apr 1, 1992·Journal of Paediatrics and Child Health·S Beal
Oct 1, 1991·Journal of Pharmacokinetics and Biopharmaceutics·L AaronsM Danhof
Jul 1, 1991·Clinical Pharmacology and Therapeutics·W F DodgeW R Snodgrass
Feb 1, 1991·Journal of Pharmacokinetics and Biopharmaceutics·D B WhiteT H Grasela
Dec 1, 1990·Journal of Pharmaceutical Sciences·N KaniwaM Ishii
Jun 1, 1988·Journal of Pharmacokinetics and Biopharmaceutics·A MalletF Lokiec
Sep 1, 1986·Clinical Pharmacokinetics·B WhitingJ Grevel
Feb 1, 1987·Journal of Pharmacokinetics and Biopharmaceutics·L B Sheiner, S L Beal
Jun 1, 1986·Clinical Pharmacology and Therapeutics·T H GraselaR B Smith
Oct 1, 1972·Computers and Biomedical Research, an International Journal·L B SheinerK L Melmon
Jan 1, 1984·European Journal of Clinical Pharmacology·E MartinL Dettli
Jan 1, 1984·Drug Metabolism Reviews·H FlühlerS Brechbühler
Dec 1, 1980·Journal of Pharmacokinetics and Biopharmaceutics·D M CocchettoJ W Crow
Dec 1, 1993·Journal of Pharmacokinetics and Biopharmaceutics·M O Karlsson, L B Sheiner
Dec 1, 1995·Journal of Pharmacokinetics and Biopharmaceutics·E I EtteB Whiting
May 13, 1998·British Journal of Clinical Pharmacology·J S SidhuL D Cong
May 29, 1998·Journal of Clinical Pharmacology·E I EtteT M Ludden
Dec 1, 1964·Journal of Pharmaceutical Sciences·G LEVY, L E HOLLISTER
Aug 26, 2004·The Annals of Pharmacotherapy·Ene I Ette, Paul J Williams

❮ Previous
Next ❯

Citations

Sep 1, 2006·Developmental Neuroscience·JoAnne E NataleAnne-Marie Guerguerian
Dec 7, 2006·American Journal of Pharmaceutical Education·Reza Mehvar
May 2, 2009·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Monica GandhiUNKNOWN Women's Interagency HIV Study
Jul 8, 2010·Nephron. Clinical Practice·Allon N FriedmanLang Li
Feb 14, 2008·Current Psychiatry Reports·Kristin L BigosRobert R Bies
Oct 15, 2011·Journal of Pharmacokinetics and Pharmacodynamics·Julia KorellStephen B Duffull
Dec 27, 2005·Vojnosanitetski pregled. Military-medical and pharmaceutical review·Jasmina R Milovanović, Slobodan M Janković
Feb 25, 2011·European Journal of Drug Metabolism and Pharmacokinetics·Marie AntignacRobert Farinotti
Apr 27, 2012·American Journal of Veterinary Research·Katharine L HopeNancy C Boedeker
Sep 17, 2013·British Journal of Clinical Pharmacology·Nikolaos TsamandourasLeon Aarons
Nov 1, 2007·Environmental Toxicology and Pharmacology·V NaidooG Swan
Nov 5, 2015·CPT: Pharmacometrics & Systems Pharmacology·R V OvergaardC W Tornøe
Aug 23, 2007·British Journal of Clinical Pharmacology·C DartoisP Girard
Nov 13, 2008·Journal of Veterinary Pharmacology and Therapeutics·V VandenbrouckeS Croubels
Sep 7, 2007·Journal of Veterinary Pharmacology and Therapeutics·K A CortrightA L Craigmill
Nov 7, 2006·Journal of Veterinary Pharmacology and Therapeutics·K A Cortright, A L Craigmill
Sep 5, 2007·Statistics in Medicine·John C BoikRobert J Boik
Jan 6, 2011·British Journal of Clinical Pharmacology·Stephen B DuffullHelen R Winter
Nov 19, 2011·Journal of Veterinary Pharmacology and Therapeutics·I A AljuffaliR D Arnold
Dec 17, 2010·Biopharmaceutics & Drug Disposition·Binfeng XiaLaura M Fox
Dec 2, 2006·The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry·Kristin L BigosBruce G Pollock
Jan 21, 2014·Advanced Drug Delivery Reviews·Charlotte I S BarkerJoseph F Standing
Aug 28, 2016·British Journal of Clinical Pharmacology·Joseph F Standing
Jan 12, 2017·Clinical Pharmacology and Therapeutics·R L HoareJ F Standing
Jan 18, 2006·The Pharmacogenomics Journal·J Lötsch, G Geisslinger
Sep 30, 2017·Statistics in Medicine·Liping Zhao, Zhiming Xia
Jun 21, 2006·Journal of Psychopharmacology·Francis E LotrichBruce G Pollock
Dec 6, 2008·The American Journal of Clinical Nutrition·Rikard LandbergAfaf Kamal-Eldin
Apr 21, 2018·Archives of Disease in Childhood·Charlotte I S BarkerMartin Offringa
Jul 10, 2008·Clinical Pharmacokinetics·Anthe S ZandvlietAlwin D R Huitema
Jul 30, 2005·Journal of Veterinary Pharmacology and Therapeutics·J E GrahamL A Tell
Apr 2, 2013·Pharmaceutical Research·Henry PertinezLeon Aarons
Jun 19, 2013·The AAPS Journal·Kelong HanRaman Venkataramanan
Sep 17, 2020·Clinical Pharmacokinetics·Tim PreijersRon A A Mathôt

❮ Previous
Next ❯

Software Mentioned

NONMEM
NLMIX
NPEM
STS
SAS
NPML
PLUS
IT2S
MIXNLIN
NLINMIX

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.